Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: April and May/SGE - worn_out
5
Feb 18, 2008 04:23PM
1
Feb 19, 2008 03:27AM

Feb 19, 2008 03:53AM
1
Feb 19, 2008 03:57AM
2
Feb 19, 2008 04:17AM
1
Feb 19, 2008 04:22AM

Feb 19, 2008 05:05AM

Retain the cash for what purpose? The cash is worth only what it's worth, and has been accumulated for the purpose of an acquisition. And more cash will come over time - a lot more IMO.

The shares should be worth progressively more over time, well over possible interest earned from cash in the bank.

As for 31 May, as I have suggested, the issue is IMO moot. Swartz has zero say per the agreement (if still in force) IF it's an all/mostly cash deal and all BoD members agree to the action.

Also consider this: with the obvious volitility of our PPS over time, would a prospective candidate for buyout want shares, or cash? To them, the shares would probably represent risk. Cash=no risk.

JMHOs,

SGE


Feb 19, 2008 06:13AM
Share
New Message
Please login to post a reply